“We adopted the SAFE digital signature standard because the data security, identity management and legal enforceability features of the SAFE standard reduce business risk for INC Research, our customers and investigators,” says Jeff Kueffer, INC chief information officer. “The SAFE standard promotes enterprise- and industrywide interoperability, a direct benefit to our customers as we reduce cost and increase quality.”
INC Research is a global organization that specializes on central nervous system, oncology and pediatric clinical research. SAFE-BioPharma is a coalition of leading biopharmaceutical companies dedicated to developing a biopharmaceutical industry trust standard. Its mission is to deliver electronic identity credentials that provide global, legally enforceable and regulatory-compliant electronic signatures.
For more information, visit www.safe-biopharma.org.
…
Add new comment